| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:2001205 | BP | negative regulation of osteoclast development | Any process that stops, prevents or reduces the frequency, rate or extent of osteoclast development. |
FBN1, LILRB1 |
GO:2001206 | BP | positive regulation of osteoclast development | Any process that activates or increases the frequency, rate or extent of osteoclast development. |
TNFSF11 |
GO:2001212 | BP | regulation of vasculogenesis | Any process that modulates the frequency, rate or extent of vasculogenesis. |
EMP2, HEY1 |
GO:2001213 | BP | negative regulation of vasculogenesis | Any process that stops, prevents or reduces the frequency, rate or extent of vasculogenesis. |
XDH |
GO:2001214 | BP | positive regulation of vasculogenesis | Any process that activates or increases the frequency, rate or extent of vasculogenesis. |
ADM, RAP1A |
GO:2001222 | BP | regulation of neuron migration | Any process that modulates the frequency, rate or extent of neuron migration. |
PLXNB2, FLRT2, ULK4, ZSWIM6 |
GO:2001223 | BP | negative regulation of neuron migration | Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration. |
GNRH1, COL3A1, STAT3, NRG1, ERBB4, ADGRG1 |
GO:2001224 | BP | positive regulation of neuron migration | Any process that activates or increases the frequency, rate or extent of neuron migration. |
SEMA3A, NSMF, KIF20B, SEMA6A |
GO:2001225 | BP | regulation of chloride transport | Any process that modulates the frequency, rate or extent of chloride transport. |
CA2 |
GO:2001229 | BP | negative regulation of response to gamma radiation | Any process that stops, prevents or reduces the frequency, rate or extent of response to gamma radiation. |
PRKDC |
GO:2001234 | BP | negative regulation of apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway. |
BCL2, CTH, CTNNB1, NR4A2, PSEN1, IGBP1, BAX, MNT, MEIS3 |
GO:2001235 | BP | positive regulation of apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway. |
INHBB, CTSH, TGFBR1, MAPK9, CTSC, CRADD, PRKCD, NFATC4, TPD52L1, TP53INP1, TRIM39 |
GO:2001236 | BP | regulation of extrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
TRAF1, DEPTOR |
GO:2001237 | BP | negative regulation of extrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
NRP1, CFLAR, SIAH2, NOL3, LMNA, IGF1, ITGAV, THBS1, GSTP1, AR, BMP4, SCG2, LGALS3, ITGA6, TGFBR1, HTT, YAP1, GCLC, GCLM, PSME3, RELA, ACVR1, RIPK1, CTTN, ZMYND11, RB1CC1, PHIP, TCF7L2, PAK7 |
GO:2001238 | BP | positive regulation of extrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
BCL10, AGT, G0S2, PDIA3, LTBR, AGTR2, TNFSF10, BID, CAV1, HYAL2, FADD, PAK2, RIPK1, GPER1, TNFRSF12A, CYLD, PYCARD |
GO:2001239 | BP | regulation of extrinsic apoptotic signaling pathway in absence of ligand | Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
FGFR1 |
GO:2001240 | BP | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
EYA2, SNAI2, EYA4, TNF, IL1A, IL1B, PF4, FYN, HSPA1A, HSPA1B, BCL2, AKT1, CTNNA1, MCL1, MAP2K5, MAPK7, RIPK1, UNC5B, STRADB |
GO:2001241 | BP | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
DAPK3, INHBA, FAS, PPP2R1A, PPP2R1B, CTNNA1, TGFB2, PPP1CA, BAX |
GO:2001242 | BP | regulation of intrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway. |
CYLD, PYCARD |
GO:2001243 | BP | negative regulation of intrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway. |
DDX3X, URI1, GCG, BCL2, MMP9, PPIF, VDAC2, PLAUR, MCL1, BCL2L2, NDUFA13, MAPK8IP1, NOC2L, IVNS1ABP |
GO:2001244 | BP | positive regulation of intrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway. |
BCL2L11, PRKRA, TP53, S100A8, S100A9, BCL2, BCAP31, BID, RACK1, CAV1, BAX, PMAIP1, SIAH1, FLCN, BAD, BCLAF1 |
GO:2001250 | BP | positive regulation of ammonia assimilation cycle | Any process that activates or increases the frequency, rate or extent of ammonia assimilation cycle. |
NR1H4 |
GO:2001256 | BP | regulation of store-operated calcium entry | Any process that modulates the frequency, rate or extent of store-operated calcium entry. |
STC2, SPINK1, HOMER1 |
GO:2001257 | BP | regulation of cation channel activity | Any process that modulates the frequency, rate or extent of cation channel activity. |
HOMER1, KCNIP2 |
GO:2001258 | BP | negative regulation of cation channel activity | Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity. |
MMP9, FGF12 |
GO:2001259 | BP | positive regulation of cation channel activity | Any process that activates or increases the frequency, rate or extent of cation channel activity. |
CTSS, ACTN2, ANK2, ANK3, KCNJ11 |
GO:2001268 | BP | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway. |
MMP9, PLAUR |
GO:2001271 | BP | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis. |
PAK2, RFFL |
GO:2001273 | BP | regulation of glucose import in response to insulin stimulus | Any process that modulates the frequency, rate or extent of glucose import in response to insulin stimulus. |
NGFR, REPIN1 |
GO:2001274 | BP | negative regulation of glucose import in response to insulin stimulus | Any process that stops, prevents or reduces the frequency, rate or extent of glucose import in response to insulin stimulus. |
PID1 |
GO:2001275 | BP | positive regulation of glucose import in response to insulin stimulus | Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus. |
AGT, PIK3R1, AKT2, IRS1, RNASEL, PTPN11, C2CD5, NR1H4, RARRES2, OSBPL8 |
GO:2001287 | BP | negative regulation of caveolin-mediated endocytosis | Any process that stops, prevents or reduces the frequency, rate or extent of caveolin-mediated endocytosis. |
UNC119 |
GO:2001288 | BP | positive regulation of caveolin-mediated endocytosis | Any process that activates or increases the frequency, rate or extent of caveolin-mediated endocytosis. |
NEDD4L |
GO:2001295 | BP | malonyl-CoA biosynthetic process | The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A. |
ACACB |
GO:2001300 | BP | lipoxin metabolic process | The chemical reactions and pathways involving a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid. |
ALOX5, HPGD |
GO:2001303 | BP | lipoxin A4 biosynthetic process | The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds. |
ALOX15 |
GO:2001311 | BP | lysobisphosphatidic acid metabolic process | The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group. |
ACP6 |